What's new? Log in Free sign up

Syros Pharmaceuticals (SYRS) Environmental, Social & Governance (ESG) Data

Company Profile

Search within these filings

View filings

Exhibits within filings

Filing insights

Export filings list

Export a CSV file of filings or unique filing companies (up to first 5,000 results).

Download list of filings Download list of companies

Employees

Data from SEC filings

Employee count

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Agriculture Climate Climate Change Environment Environmental Materials Nature Offset Package Packaging Pandemic Toxic Waste Wind Access Affordability African American Asian Attrition Benefits Black California Consumer Privacy Act Collective Bargaining Community Culture Customer Cyber Cybersecurity Data Privacy Data Security Death Disability Diversity Diversity and Inclusion Employee Employee Engagement Engagement Ethnicity Gender General Data Protection Regulation Health and Safety Health Care Healthcare Hire Hiring Hispanic Human Capital Incident Injuries Injury Latinx LGBTQ Pay Equity Privacy Recall Recruit Recruitment Reimbursement Retention Retirement Safety Satisfaction Skill Skills Social Society Stakeholder Supplier Supply Chain Supply Chain Management Talent Training Union Women Workers Workforce Workplace Safety Action Plan Anti-corruption Antitrust Assessment Assurance Attorneys General Audit Bonus Bribery Chronic Class Action Lawsuit Classified Classified Board Clawback Commitment Corporate Governance Corporate Purpose Department of Director Resignation Enterprise Risk Management ESG Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Independence Independent Innovation Innovative Investigation Lawsuit Lead Independent Director Leadership Litigation Long-term Majority Materiality Mission Oversee Oversight Plaintiff Pledging Poison Pill Purpose Quality Standard R&D Recoup Reputation Reputational Research and Development Responsibility Responsible Special Meeting Strategy Sustainability Sustainable Targets Tax Transparency Transparent Voting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.